Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current bladder tumor tests: does their projected utility fulfill clinical necessity?

V B Lokeshwar1, M S Soloway

  • 1Department of Urology, University of Miami School of Medicine, Miami, Florida, USA.

The Journal of Urology
|March 21, 2001
PubMed
Summary

Currently available noninvasive bladder cancer tests show promise for early detection and recurrence monitoring. While not replacing cystoscopy, some diagnostic markers may become crucial tools for bladder cancer management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient tolerability during office cystoscopy and bladder tumor cauterization: a multivariate analysis of risk factors.

Actas urologicas espanolas·2022
Same author

Surveillance and office management of low-grade Ta bladder tumors.

Actas urologicas espanolas·2022
Same author

Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologists.

Prostate cancer and prostatic diseases·2011
Same author

Chemotherapy of experimental transitional-cell carcinoma.

Urology·2011
Same author

Comparison of urologist reimbursement for managing patients with low-risk prostate cancer by active surveillance versus total prostatectomy.

Prostate cancer and prostatic diseases·2010
Same author

Presentation and outcome following radical cystectomy in Hispanics with bladder cancer.

International braz j urol : official journal of the Brazilian Society of Urology·2008

Area of Science:

  • Urology
  • Oncology
  • Biomarker Discovery

Background:

  • Noninvasive tests for bladder cancer are crucial for early detection of high-grade tumors and monitoring recurrence.
  • An ideal noninvasive test requires high sensitivity, specificity, speed, simplicity, and low variability.

Purpose of the Study:

  • To review existing noninvasive bladder cancer tests.
  • To evaluate their clinical utility against established diagnostic expectations.

Main Methods:

  • Literature review of commercially available and clinically useful bladder cancer tests.
  • Comparison of test performance with standard diagnostic methods.

Main Results:

  • Urine cytology has high specificity but low sensitivity; Hemastix is sensitive but not specific.

Related Experiment Videos

  • FDA-approved tests like BTA Stat, BTA TRAK, and NMP22 show variable sensitivity and specificity.
  • Emerging tests like TRAP assay and HA-HAase test demonstrate higher sensitivity and specificity.
  • Quanticyt karyometry and Immunocyt offer alternative approaches to bladder cancer detection.

    • Conclusions:

    • Current noninvasive tests do not replace cystoscopy but show clinical promise.
    • A combination of tests/markers could become a standard for bladder cancer diagnosis, pending clinical acceptance.